17 October 2024
The Rank Group Plc
LEI: 213800TXKD6XZWOFTE12
Director/PDMR Shareholding
The Rank Group Plc (the "Company") announces that it has been notified of the following transaction in the Company's ordinary 13 8/9p shares undertaken by directors / persons discharging managerial responsibility on 14 October 2024:
| Name | Position | Number of shares purchased | Number of shares sold | Total holding post-notification |
| Mark Harper | Grosvenor Venues Managing Director | 30,072 | - | 155,569 |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulations.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
| a) | Name | Mark Harper | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Grosvenor Venues Managing Director-PDMR | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | The Rank Group Plc | ||||
| b) | LEI | 213800TXKD6XZWOFTE12 | ||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary 138/9p shares
GB00B1L5QH97 | ||||
| b) | Nature of the transaction | Share purchase | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information
| Not applicable | ||||
| e) | Date of the transaction | 14 October 2024 | ||||
| f) | Place of the transaction | London Stock Exchange, Main Market (XLON) | ||||
Enquiries:
Brian McLelland, Interim Company Secretary Tel: 01628 504000
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
